Literature DB >> 35277951

Tuning Hydrogel Adhesivity and Degradability to Model the Influence of Premetastatic Niche Matrix Properties on Breast Cancer Dormancy and Reactivation.

Cindy J Farino Reyes1, John H Slater1.   

Abstract

Dormant, disseminated tumor cells (DTCs) can persist for decades in secondary tissues before being reactivated to form tumors. The properties of the premetastatic niche can influence the DTC phenotype. To better understand how matrix properties of premetastatic niches influence DTC behavior, three hydrogel formulations are implemented to model a permissive niche and two nonpermissive niches. Poly(ethylene glycol) (PEG)-based hydrogels with varying adhesivity ([RGDS]) and degradability ([N-vinyl pyrrolidinone]) are implemented to mimic a permissive niche with high adhesivity and degradability and two nonpermissive niches, one with moderate adhesivity and degradability and one with no adhesivity and high degradability. The influence of matrix properties on estrogen receptor positive (ER+ ) breast cancer cells (MCF7s) is determined via a multimetric analysis. MCF7s cultured in the permissive niche adopted a growth state, while those in the nonpermissive niche with reduced adhesivity and degradability underwent tumor mass dormancy. Complete removal of adhesivity while maintaining high degradability induced single cell dormancy. The ability to mimic reactivation of dormant cells through a dynamic increase in [RGDS] is also demonstrated. This platform provides the capability of inducing growth, dormancy, and reactivation of ER+  breast cancer and can be useful in understanding how premetastatic niche properties influence cancer cell fate.
© 2022 Wiley-VCH GmbH.

Entities:  

Keywords:  cancer; cancer metastasis; disseminated tumor cells; extracellular matrix; tissue engineering

Mesh:

Substances:

Year:  2022        PMID: 35277951      PMCID: PMC9090988          DOI: 10.1002/adbi.202200012

Source DB:  PubMed          Journal:  Adv Biol (Weinh)        ISSN: 2701-0198


  55 in total

Review 1.  Mechanisms governing metastatic dormancy and reactivation.

Authors:  Filippo G Giancotti
Journal:  Cell       Date:  2013-11-07       Impact factor: 41.582

2.  How dormant cancer persists and reawakens.

Authors:  Julio A Aguirre-Ghiso
Journal:  Science       Date:  2018-09-28       Impact factor: 47.728

3.  Geometrically Structured Microtumors in 3D Hydrogel Matrices.

Authors:  Thomas G Molley; Xiaochun Wang; Tzong-Tyng Hung; Pavithra B Jayathilaka; Jia-Lin Yang; Kristopher A Kilian
Journal:  Adv Biosyst       Date:  2020-04-08

4.  Hydrogels to engineer tumor microenvironments in vitro.

Authors:  Kanishka Fernando; Leng Gek Kwang; Joanne Tze Chin Lim; Eliza Li Shan Fong
Journal:  Biomater Sci       Date:  2021-01-13       Impact factor: 6.843

Review 5.  Metastasis prevention by targeting the dormant niche.

Authors:  Cyrus M Ghajar
Journal:  Nat Rev Cancer       Date:  2015-04       Impact factor: 60.716

6.  Breast cell invasive potential relates to the myoepithelial phenotype.

Authors:  Linda A Gordon; Kellie T Mulligan; Helen Maxwell-Jones; Matthew Adams; Rosemary A Walker; J Louise Jones
Journal:  Int J Cancer       Date:  2003-08-10       Impact factor: 7.396

Review 7.  Tumor-vascular interactions and tumor dormancy.

Authors:  George N Naumov; Judah Folkman; Oddbjorn Straume; Lars A Akslen
Journal:  APMIS       Date:  2008 Jul-Aug       Impact factor: 3.205

8.  Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line.

Authors:  C W Taylor; W S Dalton; P R Parrish; M C Gleason; W T Bellamy; F H Thompson; D J Roe; J M Trent
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

Review 9.  Interactions in the (Pre)metastatic Niche Support Metastasis Formation.

Authors:  Ginevra Doglioni; Sweta Parik; Sarah-Maria Fendt
Journal:  Front Oncol       Date:  2019-04-24       Impact factor: 6.244

Review 10.  In vitro Models of Breast Cancer Metastatic Dormancy.

Authors:  Marco Montagner; Erik Sahai
Journal:  Front Cell Dev Biol       Date:  2020-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.